Albert Steib, LCSW in Plattenville, LA - Social Worker

Albert Steib, LCSW is a Social Worker - Clinical based in Plattenville, Louisiana. Albert Steib is licensed to practice in Louisiana (license number 4198) and his current practice location is 171 La Butte Street, Plattenville, Louisiana. He can be reached at his office (for appointments etc.) via phone at (985) 513-0080.

NPI number for Albert Steib is 1619492352 and his current mailing address is Po Box 209, Plattenville, Louisiana. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1619492352.

Contact Information

	Albert Steib, LCSW
	171 La Butte Street, Plattenville, LA 70393
	(985) 513-0080
	Not Available

Healthcare Provider's Profile

Full Name	Albert Steib
Gender	Male
Speciality	Social Worker - Clinical
Location	171 La Butte Street, Plattenville, Louisiana
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1619492352
Provider Enumeration Date: 08/03/2017
Last Update Date: 08/03/2017

Medical Identifiers

Medical identifiers for Albert Steib such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1619492352	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	4198 (Louisiana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Albert Steib is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Albert Steib, LCSW Po Box 209, Plattenville, LA 70393-0209 Ph: () -	Albert Steib, LCSW 171 La Butte Street, Plattenville, LA 70393 Ph: (985) 513-0080

News Archive

Emdeon's Assistant, Claim Master solutions earn HFMA Peer Reviewed designation

Emdeon Inc., a leading provider of healthcare revenue and payment cycle management solutions, today announced that its automated patient eligibility and benefits verification tool, Emdeon® Assistant™, and web-based billing management solution, Emdeon Claim Master®, have earned the Peer Reviewed designation of the Healthcare Financial Management Association (HFMA). The HFMA Peer Reviewed designation places these Emdeon solutions on a short list of prestigious products that have been proven effective by industry expert volunteers and independent HFMA staff.

WHO releases guidance on couples testing, counseling, including ART for discordant couples

The WHO on Wednesday released its new 54-page "Guidance on couples HIV testing and counselling, including antiretroviral therapy (ART) for treatment and prevention in serodiscordant couples: Recommendations for a public health approach," according to the Center for Global Health Policy's "Science Speaks" blog.

PCI | HealthDev adds Greg Pakes as Controller

PCI | HealthDev™ formerly Physicians' Capital Investments® (the Company), a leader in medical real estate development and medical investment solutions, is pleased to announce the addition of Greg Pakes as Controller.

BioAlliance Pharma, Daewoong sign new licensing agreement for commercialization of Sitavig in South Korea

BioAlliance Pharma SA, an innovative Company specialized in the development of drugs in orphan oncology diseases, today announces an exclusive supply and license agreement for Sitavig® (Acyclovir Lauriad®) with Daewoong Pharmaceutical Co., Ltd. for commercialization rights in South Korea.

Study finds no link between AMD treatments and increase in cardiovascular complication

Newer treatments for age-related macular degeneration (AMD)-including an intravitreous (into the eye) injection of a chemotherapy drug and use of a related compound approved for use against the eye disease-do not appear to be associated with an increased risk of cardiovascular complications or death when compared with existing therapies, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

Albert Steib, LCSW - Clinical Social Worker in Plattenville, LA